Abstract | BACKGROUND AND AIMS: METHODS: The cross-sectional study comprised 6910 subjects. Antigen-antibody agglutination was evaluated by the slide test method for identification of ABO blood groups. RESULTS: CONCLUSION: Individuals with an AB blood group and high levels of anti-Hsp27 antibody titers may be predisposed to CVDs that can be mediated through the traditional CVD risk factors among middle-aged subjects from northeastern Iran. The fact that differences in anti Hsp27 are only found in the subgroup with other risk factors suggest that the difference between ABO blood groups is a consequence rather than a cause.
|
Authors | Mahdiyeh Yaghooti-Khorasani, Hamideh Ghazizadeh, Moniba Bijari, Maryam Mohammadi-Bajgiran, Mohammad Reza Oladi, Reza Zare-Feizabadi, Ameneh Timar, Shahin Nazarpour, Hamed Khedmatgozar, Mohadeseh Rohban, Elahe Hasanzadeh, Ali Javandoost, Hamed Banpoor, Mohammad Sobhan Sheikh Andalibi, Sara Moazedi, Negin Mosalman-Zadeh, Maliheh Aghasizadeh, Gordon A Ferns, Habibollah Esmaily, Majid Ghayour-Mobarhan |
Journal | Diabetes & metabolic syndrome
(Diabetes Metab Syndr)
2020 Nov-Dec
Vol. 14
Issue 6
Pg. 1689-1695
ISSN: 1878-0334 [Electronic] Netherlands |
PMID | 32905941
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- ABO Blood-Group System
- Biomarkers
- HSPB1 protein, human
- Heat-Shock Proteins
- Molecular Chaperones
- Oxidants
- Reactive Oxygen Species
- C-Reactive Protein
|
Topics |
- ABO Blood-Group System
(blood)
- Biomarkers
(blood)
- C-Reactive Protein
(metabolism)
- Cardiovascular Diseases
(blood, diagnosis, epidemiology)
- Cross-Sectional Studies
- Diabetes Mellitus
(physiopathology)
- Dyslipidemias
(physiopathology)
- Female
- Follow-Up Studies
- Heat-Shock Proteins
(blood, immunology)
- Humans
- Hypertension
(physiopathology)
- Iran
(epidemiology)
- Male
- Metabolic Syndrome
(physiopathology)
- Middle Aged
- Molecular Chaperones
(blood, immunology)
- Obesity
(physiopathology)
- Oxidants
(blood)
- Prognosis
- Reactive Oxygen Species
(blood)
- Risk Factors
|